Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation

This publication has 18 references indexed in Scilit:

• INEFFECTIVENESS OF DIPYRIDAMOLE SPECT THALLIUM IMAGING AS A SCREENING TECHNIQUE FOR CORONARY ARTERY DISEASE IN PATIENTS WITH END-STAGE RENAL FAILURE
  Transplantation, 1990
• Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography
  The American Journal of Cardiology, 1989
• Vascular changes in hemodialysis patients in response to recombinant human erythropoietin
  Kidney International, 1989
• Autonomic influence on cardiovascular performance in diabetic subjects
  The American Journal of Medicine, 1989
• Preoperative Assessment of Cardiac Patients Undergoing Noncardiac Surgical Procedures
  Mayo Clinic Proceedings, 1989
• Working capacity is increased following recombinant human erythropoietin treatment
  Kidney International, 1988
• Evaluation of cardiovascular risk for renal transplantation in diabetic patients
  The American Journal of Medicine, 1986
• Determination of Cardiac Risk by Dipyridamole-Thallium Imaging before Peripheral Vascular Surgery
  New England Journal of Medicine, 1985
• Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation
  The American Journal of Surgery, 1983
• Noninvasive detection and localization of coronary stenoses in patients: Comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging
  American Heart Journal, 1982